Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sanfang Tu
Shortening the Ex Vivo Culture of CD19‐specific CAR T‐cells Retains Potent Efficacy Against Acute Lymphoblastic Leukemia Without CRES or Severe CRS
American Journal of Hematology
Hematology
Epigenetically Deregulated miR-200c Is Involved in a Negative Feedback Loop With DNMT3a in Gastric Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CAR T Cells for Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CAR-T Cells: An Innovative Therapeutic Strategy Against Pediatric Acute Lymphoblastic Leukemia
Research in Molecular Medicine (RMM)
Locally Produced CD19 CAR T Cells Leading to Clinical Remissions in Medullary and Extramedullary Relapsed Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
PLoS ONE
Multidisciplinary
CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Immunotoxins Against CD19 and CD22 Are Effective in Killing Precursor-B Acute Lymphoblastic Leukemia Cells in Vitro
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
